Relatlimab
Drug timelines are a Plus or Pro feature.
55 regulatory and trial events tracked for Relatlimab, covering 2021-03-05 to 2026-06-26. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma [Phase 1, Phase 2]